Antiarrhythmic Drugs

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1983 Apr 23

PMID 6132656

Citations 7

Authors

W S Hillis

B Whiting

Affiliations

Soon will be listed here.

Citing Articles

Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.

Shiti A, Arbil G, Shaheen N, Huber I, Setter N, Gepstein L J Mol Cell Cardiol. 2023; 183:42-53.

PMID: 37579942 PMC: 10589759. DOI: 10.1016/j.yjmcc.2023.08.003.

Complete atrioventricular nodal block after propofol administration in an elderly patient undergoing total knee replacement arthroplasty -A case report-.

Noh J, Lee J, Woo S, Kim Y, Cho S, Kim S Korean J Anesthesiol. 2013; 64(4):363-6.

PMID: 23646248 PMC: 3640171. DOI: 10.4097/kjae.2013.64.4.363.

[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].

Pott C, Dechering D, Muszynski A, Zellerhoff S, Bittner A, Wasmer K Herzschrittmacherther Elektrophysiol. 2010; 21(4):228-38.

PMID: 21113605 DOI: 10.1007/s00399-010-0090-1.

Local anaesthetic effect of antiarrhythmic drugs and human sperm immobilization: mechanism and application of the interrelationship.

Hong C, Chiang B Br J Clin Pharmacol. 1984; 17(6):687-90.

PMID: 6743466 PMC: 1463418. DOI: 10.1111/j.1365-2125.1984.tb02404.x.

Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Muhiddin K, Turner P Postgrad Med J. 1985; 61(718):665-77.

PMID: 3898053 PMC: 2418373. DOI: 10.1136/pgmj.61.718.665.

References

Brown J, SHAND D . Therapeutic drug monitoring of antiarrhythmic agents. Clin Pharmacokinet. 1982; 7(2):125-48. DOI: 10.2165/00003088-198207020-00003. View

Ball R, SOKOLOW M . Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration. Circulation. 1956; 14(4 Part 1):568-83. DOI: 10.1161/01.cir.14.4.568. View

Gianelly R, von der Groeben J, SPIVACK A, Harrison D . Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med. 1967; 277(23):1215-9. DOI: 10.1056/NEJM196712072772301. View

ROSENBAUM M, Chiale P, Halpern M, Nau G, Przybylski J, Levi R . Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976; 38(7):934-44. DOI: 10.1016/0002-9149(76)90807-9. View

LeLorier J, Grenon D, Latour Y, Caille G, Dumont G, Brosseau A . Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med. 1977; 87(6):700-2. DOI: 10.7326/0003-4819-87-6-700. View

Nademanee K, Singh B . Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs. JAMA. 1982; 247(2):217-22. View

Campbell N, PANTRIDGE J, Adgey A . Long-term oral antiarrhythmic therapy with mexiletine. Br Heart J. 1978; 40(7):796-801. PMC: 483486. DOI: 10.1136/hrt.40.7.796. View

Bryson S, Whiting B, Lawrence J . Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability. Br J Clin Pharmacol. 1978; 6(5):409-19. PMC: 1429565. DOI: 10.1111/j.1365-2125.1978.tb04605.x. View

CARLINER N, Fisher M, Crouthamel W, Narang P, Plotnick G . Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay. Am Heart J. 1980; 100(4):483-9. DOI: 10.1016/0002-8703(80)90660-2. View

10.

Routledge P, Stargel W, Wagner G, SHAND D . Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med. 1980; 93(5):701-4. DOI: 10.7326/0003-4819-93-5-701. View

11.

Singh B, Ellrodt G, Peter C . Verapamil: a review of its pharmacological properties and therapeutic use. Drugs. 1978; 15(3):169-97. DOI: 10.2165/00003495-197815030-00001. View